Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Rios CI"'
Autor:
Charifson M; Delfina Care Inc, San Francisco, CA, United States.; Department of Population Health, New York University, New York, NY, United States., Wen T; Delfina Care Inc, San Francisco, CA, United States.; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States., Zell B; Delfina Care Inc, San Francisco, CA, United States., Vaidya P; Delfina Care Inc, San Francisco, CA, United States., Rios CI; Delfina Care Inc, San Francisco, CA, United States.; Center for Women's Health, Richmond, TX, United States., Fagbohun CF; Delfina Care Inc, San Francisco, CA, United States.; Center for Women's Health, Richmond, TX, United States., Fulcher I; Delfina Care Inc, San Francisco, CA, United States.
Publikováno v:
JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2024 Jul 12; Vol. 12, pp. e55617. Date of Electronic Publication: 2024 Jul 12.
Autor:
Rios CI; Radiation and Nuclear Countermeasures Program/Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIH), Rockville, Maryland., DiCarlo AL; Radiation and Nuclear Countermeasures Program/Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIH), Rockville, Maryland., Harrison L; Division of Biological and Physical Sciences/National Aeronautics and Space Administration, Houston, Texas., Prasanna PGS; Division of Cancer Treatment and Diagnosis/National Cancer Institute/NIH, Gaithersburg, Maryland., Buchsbaum JC; Division of Cancer Treatment and Diagnosis/National Cancer Institute/NIH, Gaithersburg, Maryland., Rudokas MW; Radiation and Nuclear Countermeasures Program/Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIH), Rockville, Maryland., Gomes LA; Radiation and Nuclear Countermeasures Program/Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIH), Rockville, Maryland., Winters TA; Radiation and Nuclear Countermeasures Program/Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2024 Apr 01; Vol. 201 (4), pp. 338-365.
Autor:
Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA., Garcia EE; Chemical Medical Countermeasures (MCM) Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Hogdahl TS 2nd; Burn/Blast MCM Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Homer MJ; Radiological/Nuclear MCM Program, Division of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS, Washington, DC, USA., Iyer NV; Burn/Blast MCM Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Laney JW; Chemical Medical Countermeasures (MCM) Program, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Loelius SG; Radiological/Nuclear MCM Program, Division of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS, Washington, DC, USA., Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), US Department of Health and Human Services (HHS), Washington, DC, USA.
Publikováno v:
Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2024 Feb 22; Vol. 18, pp. e35. Date of Electronic Publication: 2024 Feb 22.
Autor:
Molinar-Inglis O; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA., Lapinskas PJ; Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA., Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA., Silverman TA; Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA., Cassatt DR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA.
Publikováno v:
International journal of radiation biology [Int J Radiat Biol] 2024; Vol. 100 (3), pp. 486-504. Date of Electronic Publication: 2024 Jan 02.
Autor:
Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA., Andres DK; Chemical Medical Countermeasures Program, BARDA, Washington, DC, USA., Bergmann JN; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hoffman CM; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hogdahl T; Thermal Burn Medical Countermeasures Program, BARDA, Washington, DC, USA., Homer MJ; Radiological/Nuclear Medical Countermeasures Program, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Hu TC; Chemical Medical Countermeasures Program, BARDA, Washington, DC, USA., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA., Yeung DT; Chemical Countermeasures Research Program (CCRP), NIAID, NIH, Maryland, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Maryland, USA.
Publikováno v:
Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2023 Oct 19; Vol. 17, pp. e552. Date of Electronic Publication: 2023 Oct 19.
Autor:
Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Cassatt DR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Harrison-Peters JR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Hollingsworth BA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2023 Mar 01; Vol. 199 (3), pp. 301-318.
Autor:
Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Cassatt DR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Molinar-Inglis O; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland, USA.
Publikováno v:
Cytogenetic and genome research [Cytogenet Genome Res] 2023; Vol. 163 (3-4), pp. 89-102. Date of Electronic Publication: 2023 Sep 22.
Autor:
DiCarlo AL; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Cassatt DR; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Rios CI; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Satyamitra MM; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Zhang Y; Department of Epidemiology and Public Health, Marlene and Stewart Greenbaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Golden TG; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Taliaferro LP; Radiation and Nuclear Countermeasures Program; Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Publikováno v:
International journal of radiation biology [Int J Radiat Biol] 2023; Vol. 99 (7), pp. 1009-1015. Date of Electronic Publication: 2023 Feb 15.
Autor:
Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2022 Nov 01; Vol. 198 (5), pp. 508-513.
Autor:
Rios CI; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Hollingsworth BA; Previously - RNCP, DAIT, NIAID, NIH, Rockville, Maryland., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Esker JE; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC., Satyamitra MM; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Silverman TA; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC., Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Taliaferro LP; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2022 Nov 01; Vol. 198 (5), pp. 514-535.